Antidiabetic drug | 3P-MACE hazard ratio (HR) | p value | |
---|---|---|---|
PROactive | Pioglitazone | 0.84 (95% CI 0.72–0.98) | 0.02 |
ORIGIN | Insulin glargine | 1.02 (95% CI 0.94–1.11) | NS |
SAVOR | Saxagliptin | 1.00 (95% CI 0.89–1.12) | NS |
EXAMINE | Alogliptin | 0.96 (95% CI 0.80–1.15) | NS |
ELIXA | Lixisenatide | 1.02 (95% CI 0.89–1.17) | NS |
TECOS | Sitagliptin | 0.98 (95% CI 0.89–1.08) | NS |
EMPA-REG OUTCOME® | Empagliflozin | 0.86 (95% CI 0.74–0.99) | 0.038 |
LEADER® | Liraglutide | 0.87 (95% CI 0.78–0.97) | 0.01 |
SUSTAIN™-6 | Semaglutide | 0.74 (95% CI 0.58–0.95) | < 0.001a |
CANVAS-program | Canagliflozin | 0.86 (95% CI 0.75–0.97) | 0.02 |